Clients


Canada’s Stubborn Black-Market Cannabis Problem

October 26th, 2020 - Ryan Allway

Cannabis legalization came with the promise that it would prevent unnecessary incarceration, eliminate the black market and create new revenue for the government. While two of these three goals have succeeded, the black market continues to thrive in both many U.S. states and Canada despite the legalization of recreational cannabis use. Let’s take a look […]

Christina Lake Cannabis Completes Inaugural Harvest – Crop Exceeds Target by 44%, Reaching 32,500 kg

October 26th, 2020 - Ryan Allway

VANCOUVER, British Columbia, OCTOBER 26, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”), a federally licensed cultivator, processor and vendor under the Cannabis Act since 2019, is pleased to announce that the Company has exceeded its first annual cannabis production forecast by 10,000 kg (22,046 lb) – a 44.4% […]

How One Company Is Making Tryptamines & Cannabinoids Greener

October 23rd, 2020 - Ryan Allway

  Cannabinoids and tryptamines have the potential to treat a wide range of diseases, which has generated significant interest among pharmaceutical companies in accessing purified compounds. Unfortunately, these compounds are often created in agricultural or chemical synthesis processes that are time consuming, complex, expensive—and wasteful. CB Therapeutics aims to leverage its biosynthesis platform built on […]

Cybin Raises C$45 Million: The Largest Go Public Capital Raise in the Canadian Psychedelic Sector

October 22nd, 2020 - Ryan Allway

The COMPASS Pathways Inc. (NASDAQ: CMPS) initial public offering on the NASDAQ has reinvigorated the psychedelics industry over the past couple of weeks. While COMPASS Pathways Inc. is certainly one of the largest companies in the space, there are a handful of other companies, with experienced management teams, that have raised a significant amount of […]

3 Psychedelic Business Models (and What’s Best for Investors)

October 22nd, 2020 - Ryan Allway

The psychedelics industry has captured the interest of pharmaceutical companies seeking safer and more effective products to address unmet medical needs in mental health. While psychedelic molecules have shown promise, pharmaceutical manufacturers are likely to require that the molecules be improved through scientific engineering to meet specific therapeutic goals and reduce toxicities. There are three […]

ManifestSeven: From Railroads to Fiber in California’s Cannabis Industry

October 20th, 2020 - Ryan Allway

California has the world’s largest cannabis market with an estimated $12 billion in annual sales. While legal cannabis sales topped $3 billion last year, the state continues to struggle to meet high expectations with logistical and other challenges. ManifestSeven Holdings Corporation (CSE: MSVN), which recently debuted on the Canadian Securities Exchange on September 30, aspires […]

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

October 19th, 2020 - Ryan Allway

Vancouver, BC, Canada, and Irvine, CA, – October 19, 2020 — Boustead Capital Markets LLP (“Boustead”) is pleased to announce that it has been appointed by MYDECINE INNOVATIONS GROUP, INC., (CSE: MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”) to commence the dual listing process on the London Stock Exchange (“LSE” or the “Exchange”) for the admission of […]

Christina Lake Cannabis Completes Commissioning of CO2 Extraction Equipment

October 16th, 2020 - Ryan Allway

VANCOUVER, British Columbia, OCTOBER 15, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce it has completed the commissioning of its Vitalis Extraction Technology R200H-GMP-SS extraction system. The news comes days after revealing the Company has met its first-year cannabis production forecast of 22,500 kg, which will […]

Isracann Welcomes International Cannabis Exports in Israel

October 14th, 2020 - Ryan Allway

–Legal Exports Poised to Drive Domestic Industry Growth VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to announce that the government of Israel has officially […]

Christina Lake Cannabis Appoints Mervin Boychuk to Board of Directors

October 14th, 2020 - Ryan Allway

VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) is pleased to announce the appointment of Mervin Boychuk as Non-Executive Chairman of CLC’s Board of Directors as well as an Independent Director of the Company. Mr. Boychuk was a founding member on […]

Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

October 14th, 2020 - Ryan Allway

VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) — NeuroPharm, Inc. (“NeuroPharm”), a wholly-owned subsidiary of Mydecine Innovations Group, Inc., (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) announced today it has engaged FreeMind Group LLC to assist NeuroPharm in securing non-dilutive funding opportunities globally. NeuroPharm™ is developing a unique and proprietary set of pharmaceutical and natural […]

MAGICMED PRESENTS AT GRAVITAS TECHNOLOGY AND DIVERSIFIED INVESTOR DAY

October 14th, 2020 - Ryan Allway

We are pleased to announce that MagicMed Industries will be participating in the Gravitas Technology and Diversified Investor Day taking place virtually this Thursday, October 15th, 2020. MagicMed is scheduled to present at 10:45AM EST on Thursday, October 15th, 2020.  We look forward to communicating our progress, sharing our growth strategy and fielding investor questions. The Gravitas Technology and Diversified Investor Day will […]

CB Therapeutics Targets Psychedelics & Cannabis Markets

October 13th, 2020 - Ryan Allway

There’s little question that the market for cannabinoids and psychedelics are poised to experience significant growth over the coming years. While the demand for cannabinoids, like cannabidiol (CBD), has already seen tremendous growth, psychedelics represent a blue-sky market due to the potential to treat a wide range of mental health disorders. Let’s take a look […]

Christina Lake Cannabis First-Year Harvest Exceeds 22,500 kg Forecast

October 9th, 2020 - Ryan Allway

  VANCOUVER, British Columbia, OCTOBER 9, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce that as of October 8, 2020 it has met its first-year cannabis production forecast of 22,500 kg. In its inaugural grow season, CLC undertook cultivation of eight unique cannabis strains that have […]

Red White & Bloom’s Platinum Vape Expanding into Arizona

October 8th, 2020 - Ryan Allway

 Arizona’s medical market is expected to reach sales of up to $915 million for 2020; Recreational cannabis to be voted on in November’s election which would further increase market size – – Platinum’s products are currently sold within Michigan, California and Oklahoma through over 750 locations – TORONTO, Oct. 08, 2020 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. […]

Wie der Psybrary ™ die Entdeckung psychedelischer Medikamente revolutionieren könnte Teilen

October 8th, 2020 - Ryan Allway

Laut Data Bridge Market Research wird der Markt für Psychedelika in den nächsten acht Jahren voraussichtlich mit einer durchschnittlichen jährlichen Wachstumsrate von 16,3% wachsen und bis 2026 6,85 Mrd. USD erreichen. Mit der Perspektive, eine breite Palette von psychischen Störungen zu behandeln führen bereits mehrere Organisationen klinische Studien in diesem Bereich durch. Werfen wir einen […]

Who’s Who in Psychedelic Clinical Trials

October 8th, 2020 - Ryan Allway

  The psychedelic drug market could reach $6.85 billion by 2027, according to Data Bridge Market Research, which translates to a blistering 16.3% compound annual growth rate. As psychedelic treatments enter clinical trials, investors may want to keep an eye on the companies behind them as potentially coming first-to-market with revolutionary drugs. Let’s take a […]

Pure Extracts Secures Processing License from Health Canada

October 7th, 2020 - Ryan Allway

  Canada’s cannabis industry has exploded in size over the past few years. With more cultivation coming online, the retail price of cannabis biomass has fallen to about $5 per gram (including taxes) during the first quarter. The legalization and consumer trend towards cannabis extracts means that much of that dried cannabis is being processed […]

Christina Lake Cannabis Adds Sales and Business Development Leadership to its Roster

October 6th, 2020 - Ryan Allway

VANCOUVER, British Columbia, OCTOBER 6, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) a premier producer of high quality, low cost, sun-grown cannabis flower, oil cannabinoids and hemp-based extracts and derivatives, serving domestic and international markets, is pleased to announce that they have hired Rob Jones as Executive Vice President […]

Why Location Matters in Cannabis

October 5th, 2020 - Ryan Allway

The global cannabis industry has projected to be worth $73.6 billion by 2027, according to Grand View Research, which represents a blistering 18.1% compound annual growth rate. While cannabis has historically been grown indoors, outdoor cultivation has become increasingly popular over the past couple of years. Let’s take a look at the benefits of outdoor […]

Why Psychedelic Delivery Mechanisms Matter

October 2nd, 2020 - Ryan Allway

  The psychedelics industry is poised to become a nearly $7 billion market by 2027, according to Data Bridge Market Research, driven by the potential to revolutionize the treatment of mental health disorders. While investors have many options in the space, the best positioned companies are combining delivery mechanisms with novel compounds to create IP […]

Building a Cannabis Conglomerate

October 2nd, 2020 - Ryan Allway

  Investors don’t have to look hard to find conglomerates in the alcoholic beverage industry—a close proxy for the recreational cannabis industry. AB InBev (NYSE: BUD) generates about $50 billion per year in sales with more than 400 beer brands while Diageo (NYSE: DEO) generates over £10 billion in annual sales with many popular liquor […]

Christina Lake Cannabis Announces Commencement of Trading on the CSE

October 2nd, 2020 - Ryan Allway

VANCOUVER, British Columbia, OCTOBER 1, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce that its common shares will begin trading today on the Canadian Securities Exchange (“CSE”) at 9:30 am EDT on Thursday October 1, 2020 under the ticker symbol “CLC”. Christina Lake Cannabis is […]

Red White & Bloom Announces Additions to Team

October 2nd, 2020 - Ryan Allway

TORONTO, Oct. 02, 2020 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to announce new additions today to Mid-American Growers (“MAG”), a wholly owned subsidiary of the Company and promotions within its team at RWB. The Company is pleased to announce the following […]

‘Amazon of Cannabis’ ManifestSeven Makes Its Debut on the CSE

October 2nd, 2020 - Ryan Allway

  ManifestSeven Holdings Corporation (CSE: MSVN) began trading on the Canadian Securities Exchange on Wednesday. With its reverse takeover complete and its listing on the CSE launched, the first integrated omnichannel platform for legal cannabis achieved a critical milestone and set the stage for expansion over the coming year. “The listing equips M7 with an […]

Pure Extract Technologies Inc. Receives Health Canada Standard Processing License

September 30th, 2020 - Ryan Allway

Vancouver, B.C., September 30, 2020 – Big Sky Petroleum Corporation (TSX-V: BSP.H) (“Big Sky”) and Pure Extract Technologies Inc. (“Pure Extracts”) are pleased to announce that further to the Big Sky news release dated February 19, 2020 announcing its proposed acquisition (the “Proposed Transaction”) of Pure Extracts, pursuant to which Big Sky will acquire all of the […]

Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today

September 30th, 2020 - Ryan Allway

  DENVER, Colorado, USA – September 30th, 2020 – Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital telehealth mobile application for mental coaching and wellbeing, has officially launched and is available for download today: Download on Android Download on IOS […]

Christina Lake Announces Commencement of Trading on the CSE

September 29th, 2020 - Ryan Allway

September 29, 2020 17:11 ET | Source: Christina Lake Cannabis Corp. VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”), a premier producer of high-quality, low-cost, sun-grown cannabis flower, oil cannabinoids, as well as hemp-based extracts and derivatives, serving domestic and international markets, is pleased to announce […]

ManifestSeven To Begin Trading On The Canadian Securities Exchange

September 29th, 2020 - Ryan Allway

September 29, 2020 06:15 PM Eastern Daylight Time LOS ANGELES & IRVINE, Calif.–(BUSINESS WIRE)–ManifestSeven Holdings Corporation (formerly P&P Ventures Inc.) (“M7” or the “Company”), California’s first integrated omnichannel platform for legal cannabis, today announces that, in connection with the completion of its reverse takeover transaction announced in its September 25, 2020 news release, the Company’s Class […]

MindLeap Health Enters into Fast-Growing Telehealth Market

September 29th, 2020 - Ryan Allway

The COVID-19 pandemic has led to dramatic changes in healthcare. In addition to mobilizing a vaccine in record time, the pandemic could permanently alter the way that many people seek medical care, shifting from in-person to telehealth. These changes have created an enormous opportunity for companies to innovate in the remote delivery of health services. […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading